Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- ctd_human-20150221 importedOn "2015-02-21" NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_assertion wasGeneratedBy ECO_0000218 NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_assertion wasDerivedFrom ctd_human-20150221 NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_assertion SIO_000772 9452187 NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_assertion evidence source_evidence_curated NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.
- NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_assertion description "[To assess whether insulin-like growth factor-I (IGF-I), a neurotrophic agent that supports the survival of motoneurons and enhances regeneration of motor and sensory neurons, could prevent the peripheral neuropathy produced by vincristine, mice were treated with both vincristine (1.7 mg/kg, i.p., 2 x /week) and/or IGF-I (0.3 or 1 mg/kg, s.c. daily) for 10 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18525.RAYskC2Qo0HdT7dVPv1m5Jg5vYAPM6TZ5rCgRXyB5y5LE130_provenance.